Arcus Biosciences, Inc. (RCUS) Stock Overview
Explore Arcus Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Arcus Biosciences, Inc. (RCUS)
Key Financials
Key Financials
Market Cap
3.5B
P/E Ratio
-8.89
EPS (TTM)
$-3.26
ROE
-0.69%
RCUS Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Arcus Biosciences, Inc. (NYSE: RCUS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Arcus Biosciences, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of RCUS on the NYSE shows an RSI of 49.58, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $35.48 for the NYSE listing.
Key metrics behind Arcus Biosciences, Inc.'s NYSE-traded stock include a P/E ratio of -8.89 and a market capitalization of 3.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RCUS on the NYSE.